These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34718447)

  • 1. A pilot study to evaluate the safety and efficacy of treprostinil in the treatment of calcinosis in systemic sclerosis.
    Chung MP; Valenzuela A; Li S; Catanese B; Stevens K; Fiorentino D; Strand V; Chung L
    Rheumatology (Oxford); 2022 May; 61(6):2441-2449. PubMed ID: 34718447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in calcinosis over 1 year using the scleroderma clinical trials consortium radiologic scoring system for calcinosis of the hands in patients with systemic sclerosis.
    Valenzuela A; Stevens K; Chung MP; Rodriguez-Reyna TS; Proudman S; Baron M; Castelino FV; Hsu V; Green L; Galdo FD; Li S; Fiorentino D; Chung L
    Semin Arthritis Rheum; 2022 Apr; 53():151980. PubMed ID: 35183935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.
    Rannou F; Poiraudeau S; Berezné A; Baubet T; Le-Guern V; Cabane J; Guillevin L; Revel M; Fermanian J; Mouthon L
    Arthritis Rheum; 2007 Feb; 57(1):94-102. PubMed ID: 17266096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Recurrence of Digital Ulcers in Patients with Systemic Sclerosis after Discontinuation of Oral Treprostinil.
    Shah AA; Schiopu E; Chatterjee S; Csuka ME; Frech T; Goldberg A; Spiera R; Peng SL; McBride RJ; Cleveland JM; Steen V
    J Rheumatol; 2016 Sep; 43(9):1665-71. PubMed ID: 27307535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open label study of escalating doses of oral treprostinil diethanolamine in patients with systemic sclerosis and digital ischemia: pharmacokinetics and correlation with digital perfusion.
    Shah AA; Schiopu E; Hummers LK; Wade M; Phillips K; Anderson C; Wise R; Boin F; Seibold JR; Wigley F; Rollins KD
    Arthritis Res Ther; 2013 Apr; 15(2):R54. PubMed ID: 23597147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and clinical association with calcinosis cutis in early systemic sclerosis.
    Muktabhant C; Thammaroj P; Chowchuen P; Foocharoen C
    Mod Rheumatol; 2021 Nov; 31(6):1113-1119. PubMed ID: 33566708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosis.
    Valenzuela A; Baron M; Rodriguez-Reyna TS; Proudman S; Khanna D; Young A; Hinchcliff M; Steen V; Gordon J; Hsu V; Castelino FV; Schoenfeld S; Li S; Wu JY; Fiorentino D; Chung L
    Semin Arthritis Rheum; 2020 Oct; 50(5):891-896. PubMed ID: 32898758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease.
    Oudiz RJ; Schilz RJ; Barst RJ; Galié N; Rich S; Rubin LJ; Simonneau G;
    Chest; 2004 Aug; 126(2):420-7. PubMed ID: 15302727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are there risk factors for scleroderma-related calcinosis?
    Pai S; Hsu V
    Mod Rheumatol; 2018 May; 28(3):518-522. PubMed ID: 28722530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study.
    Frost A; Janmohamed M; Fritz JS; McConnell JW; Poch D; Fortin TA; Miller CE; Chin KM; Fisher M; Eggert M; McEvoy C; Benza RL; Farber HW; Kim NH; Pfister T; Shiraga Y; McLaughlin V
    J Heart Lung Transplant; 2019 Jan; 38(1):43-50. PubMed ID: 30391194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudotumoral calcinosis in systemic sclerosis: Data from systematic literature review and case series from two referral centres.
    Zanatta E; Desportes M; Do HH; Avouac J; Doria A; Feydy A; Allanore Y
    Semin Arthritis Rheum; 2020 Dec; 50(6):1339-1347. PubMed ID: 32336495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trial.
    Jing ZC; Parikh K; Pulido T; Jerjes-Sanchez C; White RJ; Allen R; Torbicki A; Xu KF; Yehle D; Laliberte K; Arneson C; Rubin LJ
    Circulation; 2013 Feb; 127(5):624-33. PubMed ID: 23307827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of rituximab for the treatment of refractory systemic sclerosis associated calcinosis: A case series and systematic review of the literature.
    Narváez J; Pirola JP; LLuch J; Juarez P; Nolla JM; Valenzuela A
    Autoimmun Rev; 2019 Mar; 18(3):262-269. PubMed ID: 30639647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of extracorporeal shock wave therapy (ESWT) in calcinosis cutis associated with systemic sclerosis.
    Blumhardt S; Frey DP; Toniolo M; Alkadhi H; Held U; Distler O
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):177-180. PubMed ID: 27494629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of calcinosis in Portuguese patients with systemic sclerosis - a multicenter study.
    Samões B; Guimarães da Fonseca D; Beirão T; Costa F; Vieira R; Terroso G; Ferreira RM; Nicolau R; Saraiva A; Salvador MJ; Duarte AC; Cordeiro A; Vilas-Boas JP; Genrinho I; Bento da Silva A; Gago L; Resende C; Martins P; Madeira N; Dinis S; Couto M; Santos I; Araújo F; Mourão AF; Gomes Guerra M; Oliveira M; Daniel A; Rodrigues M; Dantas Soares C; Parente H; Furtado C; Fontes T; Abelha-Aleixo J
    Clin Rheumatol; 2023 Aug; 42(8):2125-2134. PubMed ID: 37154983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, biochemical, and radiological characterization of the calcinosis in a cohort of Mexican patients with systemic sclerosis.
    Cruz-Domínguez MP; García-Collinot G; Saavedra MA; Medina G; Carranza-Muleiro RA; Vera-Lastra OL; Jara LJ
    Clin Rheumatol; 2017 Jan; 36(1):111-117. PubMed ID: 27718018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inorganic pyrophosphate is reduced in patients with systemic sclerosis.
    Hsu VM; Kozák E; Li Q; Bocskai M; Schlesinger N; Rosenthal A; McClure ST; Kovács L; Bálint L; Szamosi S; Szücs G; Carns M; Aren K; Goldberg I; Váradi A; Varga J
    Rheumatology (Oxford); 2022 Mar; 61(3):1158-1165. PubMed ID: 34152415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcinosis preferentially affects the thumb compared to other fingers in patients with systemic sclerosis.
    Gauhar R; Wilkinson J; Harris J; Manning J; Herrick AL
    Scand J Rheumatol; 2016 Jul; 45(4):317-20. PubMed ID: 26812367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): a randomized controlled trial.
    Tapson VF; Jing ZC; Xu KF; Pan L; Feldman J; Kiely DG; Kotlyar E; McSwain CS; Laliberte K; Arneson C; Rubin LJ;
    Chest; 2013 Sep; 144(3):952-958. PubMed ID: 23669822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiological hand involvement in systemic sclerosis.
    Avouac J; Guerini H; Wipff J; Assous N; Chevrot A; Kahan A; Allanore Y
    Ann Rheum Dis; 2006 Aug; 65(8):1088-92. PubMed ID: 16414976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.